Susquehanna Fundamental Investments’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Sell |
23,715
-111,429
| -82% | -$526K | ﹤0.01% | 692 |
|
|
2025
Q1 | $620K | Sell |
135,144
-119,701
| -47% | -$549K | 0.01% | 795 |
|
|
2024
Q4 | $1.22M | Buy |
+254,845
| New | +$1.22M | 0.02% | 646 |
|
|
2024
Q2 | $1.63M | Buy |
287,677
+5,994
| +2% | +$33.9K | 0.04% | 454 |
|
|
2024
Q1 | $1.16M | Buy |
+281,683
| New | +$1.16M | 0.05% | 322 |
|
|
2022
Q1 | – | Sell |
-36,780
| Closed | -$577K | – | 1703 |
|
|
2021
Q4 | $577K | Sell |
36,780
-12,620
| -26% | -$198K | 0.02% | 856 |
|
|
2021
Q3 | $847K | Sell |
49,400
-7,795
| -14% | -$134K | 0.02% | 941 |
|
|
2021
Q2 | $1.23M | Buy |
57,195
+1,928
| +3% | +$41.5K | 0.02% | 767 |
|
|
2021
Q1 | $830K | Buy |
55,267
+42,867
| +346% | +$644K | 0.01% | 958 |
|
|
2020
Q4 | $163K | Buy |
+12,400
| New | +$163K | ﹤0.01% | 1384 |
|
|
2020
Q3 | – | Sell |
-46,600
| Closed | -$533K | – | 1383 |
|
|
2020
Q2 | $533K | Buy |
+46,600
| New | +$533K | 0.03% | 602 |
|